(Q28251260)

English

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women

scientific article published on 25 July 2009

In more languages

Statements

scholarly article

0 references

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women (English)

0 references

0 references

1 reference

based on heuristic

inferred from title

object named as

D Apter

6

0 references

Jorge Salmerón

object named as

J Salmerón

3

0 references

object named as

F Struyf

25

0 references

Francesc Xavier Bosch José

20

object named as

F X Bosch

1 reference

ORCID Public Data File 2021

S. Rachel Skinner

10

object named as

S R Skinner

1 reference

ORCID Public Data File 2021

Suzanne Marie Garland

14

object named as

S Garland

0 references

author name string

J Paavonen

1

0 references

P Naud

2

0 references

C M Wheeler

4

0 references

S-N Chow

5

0 references

H Kitchener

7

0 references

X Castellsague

8

0 references

J C Teixeira

9

0 references

J Hedrick

11

0 references

U Jaisamrarn

12

0 references

G Limson

13

0 references

A Szarewski

15

0 references

B Romanowski

16

0 references

F Y Aoki

17

0 references

T F Schwarz

18

0 references

W A J Poppe

19

0 references

D Jenkins

21

0 references

K Hardt

22

0 references

T Zahaf

23

0 references

D Descamps

24

0 references

M Lehtinen

26

0 references

G Dubin

27

0 references

language of work or name

0 references

publication date

25 July 2009

0 references

0 references

374

0 references

9686

0 references

301-14

0 references

Age considerations when vaccinating against HPV.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961248-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Enhanced humoral and memory B cellular immunity using HPV16/18 L1 VLP vaccine formulated with the MPL/aluminium salt combination (AS04) compared to aluminium salt only

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961248-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961248-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961248-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961248-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunization of early adolescent females with human papillomavirus type 16 and 18 L1 virus-like particle vaccine containing AS04 adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961248-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine for cervical cancer prevention: a pooled analysis of 11 clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961248-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A review of cross-protection against oncogenic HPV by an HPV-16/18 AS04-adjuvanted cervical cancer vaccine: importance of virological and clinical endpoints and implications for mass vaccination in cervical cancer prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961248-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Highly effective detection of human papillomavirus 16 and 18 DNA by a testing algorithm combining broad-spectrum and type-specific PCR.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961248-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Correlation between direct ELISA, single epitope-based inhibition ELISA and pseudovirion-based neutralization assay for measuring anti-HPV-16 and anti-HPV-18 antibody response after vaccination with the AS04-adjuvanted HPV-16/18 cervical cancer vacc

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961248-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of human papillomavirus 16/18 L1 viruslike particle vaccine among young women with preexisting infection: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961248-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Persistent human papillomavirus infection and cervical neoplasia: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961248-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Persistence of an Incident Human Papillomavirus Infection and Timing of Cervical Lesions in Previously Unexposed Young Women

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961248-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961248-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Human papillomavirus genotype distributions: implications for vaccination and cancer screening in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961248-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States--a 24-year population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961248-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Incidence Trends of Adenocarcinoma of the Cervix in 13 European Countries

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961248-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Burden of cervical cancer in the United States, 1998-2003.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961248-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Etiologic heterogeneity for cervical carcinoma by histopathologic type, using comparative age-period-cohort models

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961248-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16-26 years

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961248-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in sexually active women aged 16-26 years

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961248-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961248-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961248-4

7 January 2021

based on heuristic

inferred from DOI database lookup

CIN2 is a much less reproducible and less valid diagnosis than CIN3: results from a histological review of population-based cervical samples

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961248-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Enrolment of 22,000 adolescent women to cancer registry follow-up for long-term human papillomavirus vaccine efficacy: guarding against guessing

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961248-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Human papillomavirus (HPV) vaccines: limited cross-protection against additional HPV types.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961248-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961248-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Development and duration of human papillomavirus lesions, after initial infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961248-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Analysis of adverse events of potential autoimmune aetiology in a large integrated safety database of AS04 adjuvanted vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961248-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28251260&oldid=1616189063"